Search Results - "Garner, Sarah E"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Minocycline for acne vulgaris: efficacy and safety by Garner, Sarah E, Eady, Anne, Bennett, Cathy, Newton, John Norman, Thomas, Karen, Popescu, Catalin Mihai

    Published in Cochrane database of systematic reviews (15-08-2012)
    “…Minocycline is an oral antibiotic used for acne vulgaris. Its use has lessened due to safety concerns (including potentially irreversible pigmentation), a…”
    Get more information
    Journal Article
  2. 2

    Interventions to improve the use of systematic reviews in decision-making by health system managers, policy makers and clinicians by Murthy, Lakshmi, Shepperd, Sasha, Clarke, Mike J, Garner, Sarah E, Lavis, John N, Perrier, Laure, Roberts, Nia W, Straus, Sharon E

    Published in Cochrane database of systematic reviews (12-09-2012)
    “…Systematic reviews provide a transparent and robust summary of existing research. However, health system managers, national and local policy makers and…”
    Get more information
    Journal Article
  3. 3

    Interventions for hidradenitis suppurativa by Ingram, John R, Woo, Pick-Ngor, Chua, Ser Ling, Ormerod, Anthony D, Desai, Nemesha, Kai, Anneke C, Hood, Kerry, Burton, Tara, Kerdel, Francisco, Garner, Sarah E, Piguet, Vincent

    Published in Cochrane database of systematic reviews (07-10-2015)
    “…Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterised by recurrent painful boils in flexural sites, such as the axillae and…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Combined oral contraceptive pills for treatment of acne by Arowojolu, Ayodele O, Gallo, Maria F, Lopez, Laureen M, Grimes, David A, Garner, Sarah E

    Published in Cochrane database of systematic reviews (08-07-2009)
    “…Acne is a common skin disorder among women. Although no uniform approach to the management of acne exists, combination oral contraceptives (COCs), which…”
    Get more information
    Journal Article
  6. 6

    Rofecoxib for rheumatoid arthritis by Garner, S E, Fidan, D D, Frankish, R R, Judd, M G, Towheed, T E, Wells, G, Tugwell, P

    Published in Cochrane database of systematic reviews (24-01-2005)
    “…Editor's note: The anti-inflammatory drug rofecoxib (Vioxx) was withdrawn from the market at the end of September 2004 after it was shown that long-term use…”
    Get more information
    Journal Article
  7. 7

    Rofecoxib for osteoarthritis by Garner, S E, Fidan, D D, Frankish, R, Maxwell, L

    Published in Cochrane database of systematic reviews (24-01-2005)
    “…Editor's note: The anti-inflammatory drug rofecoxib (Vioxx) was withdrawn from the market at the end of September 2004 after it was shown that long-term use…”
    Get more information
    Journal Article
  8. 8
  9. 9

    WITHDRAWN: Celecoxib for rheumatoid arthritis by Garner, Sarah E, Fidan, Dogan, Frankish, Ruth R, Judd, Maria, Shea, Beverley, Towheed, Tanveer, Tugwell, Peter, Wells, George A

    Published in Cochrane database of systematic reviews (09-06-2017)
    “…Rheumatoid arthritis (RA) is a systemic auto-immune disorder, involving persistent joint inflammation. NSAIDs are used to control the symptoms of RA, but are…”
    Get more information
    Journal Article
  10. 10

    Interventions for pityriasis rosea by Chuh, A A T, Dofitas, B L, Comisel, G G, Reveiz, L, Sharma, V, Garner, S E, Chu, F

    Published in Cochrane database of systematic reviews (18-04-2007)
    “…Pityriasis rosea is a scaly rash that mainly affects young adults. It can be very itchy but most people recover within 2 to 12 weeks. To assess the effects of…”
    Get more information
    Journal Article
  11. 11

    Nitric oxide production and perivascular tyrosine nitration in brain after carbon monoxide poisoning in the rat by Ischiropoulos, H, Beers, M F, Ohnishi, ST, Fisher, D, Garner, SE, Thom, SR

    Published in The Journal of clinical investigation (15-05-1996)
    “…Nitric oxide is a short-lived free radical and physiological mediator which has the potential to cause cytotoxicity. Studies were conducted to investigate…”
    Get full text
    Journal Article
  12. 12

    [125I](S)-trans-7-OH-PIPAT: a potential spect imaging agent for sigma binding sites by Garner, S E, Kung, M P, Foulon, C, Chumpradit, S, Kung, H F

    Published in Life sciences (1973) (1994)
    “…[125I](S)-trans-7-hydroxy-2-[(N-n-propyl-N-(3'-iodo-2'-propenyl)] aminotetralin ([125I](S)-trans-7-OH-PIPAT) has been prepared as an iodinated radioligand for…”
    Get more information
    Journal Article